Development and Characterization of a Novel Congenic Rat Strain for Obesity and Cancer Research

ABSTRACT

The association between a Western Diet and colon cancer suggests that dietary factors and/or obesity may contribute to cancer progression. Our objective was to develop a new animal model of obesity and the associated pathophysiology to investigate human cancer independent of dietary components that induce obesity.

A novel congenic rat strain was established by introducing the fa allele from the Zucker rat into the Rowett Nude rat to generate a “fatty nude rat”. The obese phenotype was first characterized in the new model. To then examine the utility of this model, lean and obese rats were implanted with HT-29 human colon cancer xenografts and tumor growth monitored.

Fatty nude rats were visibly obese and did not develop fasting hyperglycemia. Compared to lean rats, fatty nude rats developed fasting hyperinsulinemia, glucose intolerance, and insulin resistance. Colon cancer tumor growth rate and final weight were increased (P < 0.05) in fatty nude compared to lean rats. Final tumor weight was associated with p38 kinase phosphorylation (P < 0.01) in fatty nude rats.

We have established a novel model of obesity and pre-type 2 diabetes that can be used to investigate human cancer and therapeutics in the context of obesity and its associated pathophysiology.

Additional information

Funding

This work has been supported by the Stephen C. Clark Fund (MWG), E. Donnall Thomas Resident Research Fund (EAG), a Tulane University School of Medicine and Louisiana Cancer Research Consortium Startup Grant (DEB), and an Auburn University Startup Grant (MWG).